Our technology transfer service unit, ZBM BConnect (ZBM BC) has announced that its client University of the Balearic Islands (UIB) has signed a license option agreement with the Valencia-based company Polypeptide Therapeutic Solutions S.L. (PTS).

Under the agreement PTS is granted an option to acquire a license to UIB’s patented technology to produce highly specialized polymers developed jointly by researchers from the University of the Balearic Islands (UIB) and the London School of Hygiene and Tropical Medicine (LSHTM). The polymers are highly suitable for delivering biological active substances. These novel drug delivery vehicles show promising potential in new pharmaceuticals and vaccines.

PTS specializes in the design and manufacture of precision polymers and is a leading supplier of specialized polymers for vaccines and drug delivery. “We are excited about this opportunity to make available to the pharmaceutical industry the technology that was jointly developed by UIB and LSHTM”, says Vicent Josep Nebot, Chief Technical Officer of PTS.

Research groups at the UIB have been working on therapeutic applications of specialized peptide-like polymers for more than a decade. “We have maintained an exciting collaboration with LSHTM for several years now, and we are proud of pulling off highly efficient drug delivery tools to the community. These have come out of the joint efforts and hard work between both teams”, research team members say.

“ZBM BC has been a strategic partner for us providing a valuable commercial insight and assisting UIB throughout the technology transfer process. They are top professionals, which know how to smoothly and efficiently facilitate the work”, says Lorena Vela, Technician of Technology Transfer, UIB.

Bernabé Zea, CEO of ZBM BC, says “This is an example of the type of services we provide to our clients. We appreciate this opportunity to assist UIB in negotiating and closing this deal with a leading commercial supplier of precision polymers.”

ZBM BConnect, with offices in Barcelona, Madrid, Copenhagen and Oxford, has several years of experience in assisting universities, public research institutes and start-up companies in identifying commercial partners and providing support during the process of successfully negotiating and finalizing technology transfer agreements.

For more information about ZBM BC’s service offerings please visit ZBM BConnect.

The following inventors have contributed to the development of the patented technology:

Antonio Costa Torres ✧, Maria del Carmen Rotger Pons ✧, Priam Francesc de Villalonga Smith ✧, Silvia Elena Fernández de Mattos ✧, Francisca Orvay Pintos ✧, Francisco Olmo Arévalo ✦, and John Morrison Kelly ✦